United States Antibiogram: Difference between revisions

No edit summary
Line 20: Line 20:
| ||[[Penicillin V]]||+||+||+/-||+||+||+/-||0||0||0||0||0||0
| ||[[Penicillin V]]||+||+||+/-||+||+||+/-||0||0||0||0||0||0
|-
|-
| Anti-Staphylocccal Penicillins||[[Methicillin]]||+||+||+/-||+||0||0||+||0||0||+||0||0
| Anti-Staphylocccal Penicillins||Methicillin||+||+||+/-||+||0||0||+||0||0||+||0||0
|-
|-
| ||[[Nafcillin]]/[[Oxacillin]]||+||+||+/-||+||0||0||+||0||0||+||0||0
| ||Nafcillin/Oxacillin||+||+||+/-||+||0||0||+||0||0||+||0||0
|-
|-
| ||[[Cloxacillin]]/[[Diclox.]]||+||+||+/-||+||0||0||+||0||0||+||0||0
| ||Cloxacillin/Diclox.||+||+||+/-||+||0||0||+||0||0||+||0||0
|-
|-
| Amino-Penicillins||[[AMP]]/[[Amox]]||+||+||+/-||+||+||+||0||0||0||0||0||+
| Amino-Penicillins||[[AMP]]/[[Amox]]||+||+||+/-||+||+||+||0||0||0||0||0||+

Revision as of 19:56, 25 March 2014

Gram Positives

' ' Strep. Group A, B, C, G Strep. Pneumoniae Viridans strep Strep. milleri Enterococcus faecalis Enterococcus faecium Staph. aureus (MSSA) Staph. aureus (MRSA) Staph. aureus (CA-MRSA) Staph. Epidermidis C. jeikeium L. monocytogenes
Penicillins Penicillin G + + +/- + + +/- 0 0 0 0 0 +
Penicillin V + + +/- + + +/- 0 0 0 0 0 0
Anti-Staphylocccal Penicillins Methicillin + + +/- + 0 0 + 0 0 + 0 0
Nafcillin/Oxacillin + + +/- + 0 0 + 0 0 + 0 0
Cloxacillin/Diclox. + + +/- + 0 0 + 0 0 + 0 0
Amino-Penicillins AMP/Amox + + +/- + + + 0 0 0 0 0 +
Amox-Clav + + +/- + + + + 0 0 0 0
AMP-Sulb + + +/- + + + + 0 0 0 0 +
Anti-Pseudomonal Penicillins Ticarcillin + + +/- + +/- +/- 0 0 0 +/- 0 +
Ticar-Clav + + +/- + +/- +/- + 0 0 +/- 0
Pip-Tazo + + +/- + + +/- + 0 0 +
Carbapenems Piperacillin + + +/- + + +/- 0 0 0 0 0 +
Doripenem + + + + +/- 0 + 0 0 + +
Ertapenem + + + + 0 0 + 0 0 + 0 +/-
Imipenem + + + + + +/- + 0 0 + 0 +
Meropenem + + + + +/- 0 + 0 0 + +
Aztreonam 0 0 0 0 0 0 0 0 0 0 0 0
Fluroquinolones Ciprofloxacin +/- +/- 0 0 ^^ 0 + 0 +/- + 0 +
Ofloxacin +/- +/- 0 0 ^^ 0 + 0 + 0 0
Pefloxacin 0 0 0 0 + 0 + 0
Levofloxacin + + + + + 0 + 0 +/- + +
Moxifloxacin + + + + + +/- + +/- +/- + +
Gemifloxacin + + + + + +/- + +/- +/- + +
Gatifloxacin + + + + + +/- + +/- +/- + +
1st G Cephalosporins Cefazolin + + + 0 + 0 0 +/- 0 0
2nd G. Cephalosporins Cefotetan + + + 0 + 0 0 +/- 0 0
Cefoxitin + + + 0 + 0 0 +/- 0 0
Cefuroxime + + + 0 + 0 0 +/- 0 0
3rd/4th G. Cephalosporins Cefotaxime + + + 0 + 0 0 +/- 0 0
Cefizoxime + + + 0 + 0 0 +/- 0 0
CefTRIAXone + + + 0 + 0 0 +/- 0 0
Ceftobiprole + + + + + + + +
Ceftaroline + + + + + + + +
CefTAZidime + + +/- 0 +/- 0 0 +/- 0 0
Cefepime + + + 0 + 0 0 +/- 0
Oral 1st G. Cephalosporins Cefadroxil + + + 0 + 0 0 +/- 0 0
Cephalexin + + + 0 + 0 0 +/- 0 0
Oral 2nd G. Cephalosporins Cefaclor/Loracarbef + + + 0 + 0 0 +/- 0 0
Cefproxil + + 0 0 + 0 0 +/- 0 0
Cefuroxime axetil + + + 0 + 0 0 +/- 0 0
Oral 3rd G. Cephalosporins Cefixime + + + 0 0 0 0 0 0 0
Ceftibuten + +/- 0 0 0 0 0 0 0 0
Cefpodox/Cefdinir/Cefditoren + + + 0 + 0 0 +/- 0
Aminoglycosides Gentamicin 0 0 S S + 0 +/- 0 S
Tobramycin 0 0 S 0 + 0 +/- 0 S
Amikacin 0 0 S 0 + 0 +/- 0 S
Chloramphenicol + + +/- +/- +/- 0 0 0 +
Clindamycin + + 0 0 + 0 +/- 0 0
Macrolides Erythromycin +/- + 0 0 +/- 0 +/- +/- 0 +
Azithromycin +/- + 0 0 + 0 +/- 0 0 +
Clarithromycin +/- + 0 0 + 0 +/- 0 0 +
Ketolide Telithromycin + +/- +/- 0 + 0 +/- 0 0 +
Tetracyclines Doxycycline +/- + 0 0 +/- +/- + 0 0 +
Minocycline + + 0 0 +/- +/- + 0 0 +
Glycylcycline Tigecycline + + + + + + + + + +
Glyco/Lipoclycopeptides Vancomycin + + + +/- + + + + + +
Teicoplanin + + + +/- + + + +/- + +
Telavancin + + + + + + + + + +
Fusidic Acid +/- +/- + + + + + +
Trimethoprim + +/- + 0 +/- +/- + + 0 +
TMP-SMX + + + 0 + + + +/- 0 +
Urinary Agents Nitrofurantoin + + + + + + + 0
Fosfomycin + +/-
Other Rifampin + + +/- 0 + + + + 0 +
Metronidazole 0 0 0 0 0 0 0 0 + 0
Quinupristin dalfoppristin + + 0 + + + + + + +
Linezolid + + + + + + + + + +
Daptomycin + + + + + + + + 0 +/-
Colistimethate 0 0 0 0 0 0 0 0 0

Key

  • + usually effective clinically or >60% susceptible
  • +/- clinical trials lacking or 30-60% susceptible
  • 0 not effective clinically or <30% susceptible
  • blank data not available

See Also

Source

Sanford Guide to Antimicrobial Therapy 2010